CN Stock MarketDetailed Quotes
000518 Jiangsu Sihuan Bioengineering
- 2.40
- +0.11+4.80%
Not Open May 6 15:00 CST
2.47BMarket Cap-41379P/E (TTM)
2.40High2.26Low393.65KlotVolume2.32Open2.29Pre Close92.10MTurnover3.82%Turnover RatioLossP/E (Static)1.03BShares4.5752wk High5.16P/B2.47BFloat Cap1.7252wk Low2.52Limit Up1.03BShs Float10.50Historical High2.06Limit Down6.11%Amplitude0.26Historical Low--Dividend TTM2.34Avg Price161.03KlotAsk--Div YieldTTM100Lot Size234.62KlotBid
About Jiangsu Sihuan Bioengineering Company
The company was founded on May 18, 1992. On April 26, 1993, the company was listed on the Shenzhen Stock Exchange with the approval of the National Sports Reform Commission Document No. 87 (1992) and Su Zhengfu (1992) Document No. 62 of the Jiangsu Provincial People's Government. The company is mainly engaged in biomedical products, production and sales, and landscaping engineering business. The company's main products include EPO injections, injectable interleukin-2, etc.
Company Profile
Short Name-A四环生物
Symbol-A000518
Company NameJIANSU SIHUAN BIOENGINEERING CO.，LTD
Listing DateSep 8, 1993
Issue Price1.00
Shares Offered40.00M share(s)
FoundedMay 18, 1992
Listed ExchangeSZ Stock Exchange
Legal Representativeyu guo
CEOyu guo
Secretaryyu guo
Accounting FirmChina Audit Asia Pacific Certified Public Accountants (Special General Partnership)
Legal CounselJiangsu Century Tongren Law Firm
Employees3
Phone0510-86408558
Office AddressNo. 6, Zhongfang, Xinyu Road, Xinqiao Town, Jiangyin City, Jiangsu Province
Zip Code214426
Registered AddressNo. 10, Dingshan Road, Binjiang Development Zone, Jiangyin City, Jiangsu Province
Fax0510-86408558
Email0518shsw@163.com
Websitehttp://www.000518shsw.com/
Business License320200000015084
BusinessLicensed business projects: Large-capacity injections (including multi-layer co-extruded membrane infusion bags), small-volume injections (including antineoplastic drugs), tablets (including antineoplastic agents), hard capsules, syrups, oral solutions, alcohol, APIs, traditional Chinese medicine extraction, manufacturing of class II psychotropic drugs, snowfield bone treasure (capsules, tablets), Bolton brand, and Inman gold spirulina selenide tablets. General business projects: medical information consulting; technology transfer services; pharmaceutical intermediates manufacturing (except chemical dangerous goods); manufacture and sale of woolen textiles, cashmere products, knitwear, chemical fibers, and chemical products (except dangerous goods); sales of electronic products, communications, radio and television equipment (excluding terrestrial reception facilities and transmitters for satellite television broadcasting); industrial investment; export business of products and technology produced by the enterprise itself; operating the import business of raw materials, instruments, machinery equipment, spare parts and technology required for the enterprise's production and scientific research (prohibited by the state limited companies and countries) Excluding imported and exported goods and technology), which engages in feedstock processing and “three to one supplement” business; landscaping projects. (Subject to approval by the Ministry of Industry and Commerce)
Company Executives
- Name
- Position
- Salary
- yu guo
- Chairman，directors，general manager，Acting Secretary to the Board
- 283.00K
- jun wen
- directors
- 574.40K
- yu lu
- directors
- --
- wei liu
- Independent directors
- 80.00K
- liangwei wu
- Independent directors
- 80.00K
- li wang
- Independent directors
- 40.00K
- lei wang
- Chairman of the Supervisory Board，Shareholder Supervisors
- 48.10K
- like xu
- Shareholder Supervisors
- 59.80K
- jie zhao
- Chief Financial Officer
- --
- jingxuan hua
- Employee supervisors
- --
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg